Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility

69Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

Abstract

Gene dosage has frequently been exploited to select for genetic interactions between a particular mutant and clones from a random genomic library at high copy. We report here the first use of multicopy suppression as a forward genetic method to determine cellular targets and potential resistance mechanisms for novel antibacterial compounds identified through high-throughput screening. A screen of 8640 small molecules for growth inhibition of a hyperpermeable strain of Escherichia coli led to the identification of 49 leads for suppressor selection from clones harboring an E. coli genomic library. The majority of suppressors were found to encode the multidrug efflux pump AcrB, indicating that those compounds were substrates for efflux. Two leads, which produced clones containing the gene folA, encoding dihydrofolate reductase (DHFR), proved to target DHFR in vivo and were competitive inhibitors in vitro.

Cite

CITATION STYLE

APA

Li, X., Zolli-Juran, M., Cechetto, J. D., Daigle, D. M., Wright, G. D., & Brown, E. D. (2004). Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. Chemistry and Biology, 11(10), 1423–1430. https://doi.org/10.1016/j.chembiol.2004.08.014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free